| 1. | rudihorne | |
| 2. | flowcobra | |
| 3. | ResearcherOfStocks | |
| 4. | BuyHighSellLow | |
| 5. | vote4amazon |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | flowcobra 10/10/2017 CEO just bought 9k shares after market. |
| 2. | ResearcherOfStocks 10/05/2017 Outlook for FDA Approval of Zilretta |
| 3. | rudihorne 04/18/2018 Flexion Therapeutics Announces Publication of Results from Pivotal Phase 3 Study of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) in the Journal of Bone and Joint Surgery |
| 4. | blackopsstreet 04/25/2018 Flexion Therapeutics to Present Data on ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) at the Academy of Managed Care Pharmacy Annual Meeting 2018 |
| 5. | vote4amazon 02/01/2018 Berenberg initiates as a buy |
| 6. | BuyHighSellLow 10/10/2017 I sold last week in 31's |
| 7. | flowcobra 10/05/2017 Hits mid 30's Friday or Monday. |
| 8. | flowcobra 10/08/2017 Should should be good |
| 9. | BuyHighSellLow 10/05/2017 CEO has also made it clear that most OA knee patients will eventually need knee replacement surgery. 2nd line treatments delay it. Read this is you have a chance: {Link} |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Flexion Therapeutics, Inc.
- FLXN
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.